$205.51 +3.49 (%) Valeant Pharmaceuticals International Inc - NYSE

Apr. 28, 2015 | 04:00 PM

Partner Headlines

  1. 4 Top-Rated Drugmakers Reporting Earnings This Week

    IBD | Apr. 26, 2015 | 08:02AM EST
  2. Submit Questions for Upcoming Q&A With Value Investor Wally Weitz

    GuruFocus | Apr. 24, 2015 | 14:42PM EST
  3. Autohome, Other Foreign Stock Leaders Seen Posting Big Q1 Growth

    IBD | Apr. 13, 2015 | 17:17PM EST
  4. The Top Guru-Held Canadian Stocks

    GuruFocus | Apr. 11, 2015 | 23:51PM EST
  5. Big Cap 20 Reflecting Market Leadership

    IBD | Mar. 2, 2015 | 18:44PM EST
  6. IBD 50 Performance Ramps Up; Several Setups Emerge

    IBD | Feb. 27, 2015 | 18:45PM EST
  7. Meet IBD's 4 A Stocks With Rising Earnings Estimates

    IBD | Feb. 27, 2015 | 16:27PM EST
  8. Meet IBD's 4 A Stocks With Rising Earnings Estimates

    IBD | Feb. 26, 2015 | 19:47PM EST
  9. Jazz Pharmaceuticals Tops Q4 Earnings And Tests Buy Point

    IBD | Feb. 26, 2015 | 11:51AM EST
  10. Morgan Stanley Reiterates Overweight, Raises Price Target On Valeant Pharmaceuticals On New Proforma Model For SLXP

    Benzinga | Feb. 26, 2015 | 09:22AM EST
  11. Biotech Pharmacyclics Spikes On Buyout Rumors

    IBD | Feb. 25, 2015 | 14:31PM EST
  12. Here's Why CRT Capital Boosted Valeant Pharmaceuticals' Price Target

    Benzinga | Feb. 25, 2015 | 11:31AM EST
  13. Valeant Pharmaceuticals Is Kicking Butt, Says Canaccord Genuity

    Benzinga | Feb. 24, 2015 | 16:00PM EST
  14. Lannett Joins Big-Game Hunt For Drugmaker Acquisitions

    IBD | Feb. 24, 2015 | 15:58PM EST
  15. Firms Bullish On Valeant Following Earnings, Acquisition

    Benzinga | Feb. 24, 2015 | 13:44PM EST
  16. Valeant Pharmaceuticals Finally Zeros In On Salix Pharmaceuticals

    GuruFocus | Feb. 24, 2015 | 12:09PM EST
  17. 4 Pictures Every Valeant-Salix Investor Should See

    Benzinga | Feb. 23, 2015 | 18:59PM EST
  18. Taxes Put U.S. Firms On Sale

    IBD | Feb. 23, 2015 | 18:54PM EST
  19. Tax System Gives Edge To Foreign Buys Of U.S. Firms

    IBD | Feb. 23, 2015 | 18:51PM EST
  20. Bristol-Myers goes for the gut

    IBD | Feb. 23, 2015 | 18:33PM EST
  21. Nasdaq Stretches Win Streak To 9 Days

    IBD | Feb. 23, 2015 | 17:03PM EST
  22. Nasdaq Climbs As Apple Stock Hits New High

    IBD | Feb. 23, 2015 | 16:23PM EST
  23. Biotech Stocks Moving Higher

    Benzinga | Feb. 23, 2015 | 15:35PM EST
  24. Drugmaker Mylan Takes Part In Pharma Feeding Frenzy

    IBD | Feb. 23, 2015 | 14:59PM EST
  25. JMP Securities Comments On Salix Pharmaceutical's Takeover Valuation

    Benzinga | Feb. 23, 2015 | 14:41PM EST
  26. Valeant CEO Explains Why The Company Is Acquiring Salix For $10.1 Billion Cash Instead Of An Equity Offering

    Benzinga | Feb. 23, 2015 | 14:27PM EST
  27. Stocks Quietly Lower; Domino's, Medivation Break Out

    IBD | Feb. 23, 2015 | 13:18PM EST
  28. Pharma M&A: Bristol-Myers, Valeant Make Deals

    IBD | Feb. 23, 2015 | 12:41PM EST
  29. Stocks Edge Lower, Oil Falls, But Managed-Care Firms Shine

    IBD | Feb. 23, 2015 | 11:47AM EST
  30. Update: Marathon Pharma Sold Hospital Products To Valeant

    Benzinga | Feb. 23, 2015 | 10:42AM EST
  31. Cramer: Valeant's Stock Doesn't Stop Here, It Goes Higher

    Benzinga | Feb. 23, 2015 | 10:29AM EST
  32. Stocks Open Quietly in The Red; Nationstar, Valeant, Tower Rise

    IBD | Feb. 23, 2015 | 10:24AM EST
  33. Benzinga's Volume Movers

    Benzinga | Feb. 23, 2015 | 10:22AM EST
  34. Stocks Hitting 52-Week Highs

    Benzinga | Feb. 23, 2015 | 10:12AM EST
  35. Morning Market Gainers

    Benzinga | Feb. 23, 2015 | 09:44AM EST
  36. Stock Futures Dip, But Not Much; Valeant, Polypore, AerCap Surge

    IBD | Feb. 23, 2015 | 09:07AM EST
  37. Monday's #PreMarket Movers: Spectrum Pharmaceuticals, Cyberark Software Trending Down

    Benzinga | Feb. 23, 2015 | 08:57AM EST
  38. US Stock Futures Slip Ahead Of Economic Data

    Benzinga | Feb. 23, 2015 | 07:12AM EST
  39. Valeant Pharmaceuticals Will Buy Salix For $14.5 Billion

    IBD | Feb. 22, 2015 | 17:46PM EST
  40. Benzinga's Weekend M&A Chatter

    Benzinga | Feb. 22, 2015 | 17:17PM EST
  41. A Look At 5 IBD 50 Stocks With Upcoming Earnings

    IBD | Feb. 21, 2015 | 08:02AM EST
  42. Valeant Pharmaceuticals

    IBD | Feb. 20, 2015 | 18:40PM EST
  43. Stocks Cap Short Week With Gains; Salix Up On Buyout Hopes

    IBD | Feb. 20, 2015 | 16:58PM EST
  44. Greek Deal Lifts Nasdaq Near Dot-Com Bubble High

    IBD | Feb. 20, 2015 | 16:23PM EST
  45. Boeing Lifts Dow; Nasdaq Gets Apple Boost

    IBD | Feb. 20, 2015 | 14:56PM EST
  46. Market Turns Positive As Stocks Stage Reversal

    IBD | Feb. 20, 2015 | 13:32PM EST
  47. Medical Stocks Rise; Valeant Said To Be Near Buy Of Salix

    IBD | Feb. 20, 2015 | 11:54AM EST
  48. Novo Nordisk Pops On Successful Diabetes Drug Trial

    IBD | Feb. 20, 2015 | 11:42AM EST
  49. Stephen Mandel's Lone Pine Capital Loves Tech, Consumer Stocks

    Benzinga | Feb. 18, 2015 | 17:18PM EST
  50. Fourth-Quarter Acquisitions Rearrange Jana Partners' Portfolio

    GuruFocus | Feb. 18, 2015 | 16:52PM EST
Trading Center